New research frontiers pertaining to the infant gut microbiota

Abstract

The human gut microbiota is believed to be responsible for multiple health-impacting host effects. The influence of gut microorganisms on the human host begins immediately after birth, having long-lasting health effects, while the gut microbiota itself continues to develop throughout the host’s entire life. The purported health-associated effects of the gut microbiota have fueled extensive and ongoing research efforts. Nonetheless, the precise mode of action of functionalities exerted by microbial colonizers of the infant intestine is still largely unknown. The current perspective intends to illustrate major future investigative directions concerning the human gut microbiota with a specific focus on infant-associated gut microbes.

Keywords

Microbiome, metagenomics, culturomics, microbe-microbe interactions / host-microbe interactions

References

[1] Lozupone CA,Gordon JI,Knight R.Diversity, stability and resilience of the human gut microbiota.Nature2012;489:220-30 PMCID:PMC3577372

[2] Bokulich NA,Battaglia T.Antibiotics, birth mode, and diet shape microbiome maturation during early life.Sci Transl Med2016;8:343ra82 PMCID:PMC5308924

[3] Yassour M,Siljander H.Natural history of the infant gut microbiome and impact of antibiotic treatment on bacterial strain diversity and stability.Sci Transl Med2016;8:343ra81 PMCID:PMC5032909

[4] Yatsunenko T,Manary MJ.Human gut microbiome viewed across age and geography.Nature2012;486:222-7 PMCID:PMC3376388

[5] Eggesbø M,Stigum H,Magnus P.Is delivery by cesarean section a risk factor for food allergy?.J Allergy Clin Immunol2003;112:420-6

[6] Milani C,Bottacini F.The first microbial colonizers of the human gut: composition, activities, and health implications of the infant gut microbiota.Microbiol Mol Biol Rev2017;81:e00036-17 PMCID:PMC5706746

[7] Sevelsted A,Bønnelykke K.Cesarean section and chronic immune disorders.Pediatrics2015;135:e92-8

[8] Jackson MA,Maxan ME.Gut microbiota associations with common diseases and prescription medications in a population-based cohort.Nat Commun2018;9:2655 PMCID:PMC6037668

[9] Yassour M,Hogstrom LJ.Strain-level analysis of mother-to-child bacterial transmission during the first few months of life.Cell Host Microbe2018;24:146-154.e4 PMCID:PMC6091882

[10] Milani C,Lugli GA.Exploring vertical transmission of bifidobacteria from mother to child.Appl Environ Microbiol2015;81:7078-87 PMCID:PMC4579462

[11] Lagier JC,Million M.Culturing the human microbiota and culturomics.Nat Rev Microbiol2018;16:540-50

[12] Bellais S,Ania M.Species-targeted sorting and cultivation of commensal bacteria from the gut microbiome using flow cytometry under anaerobic conditions.Microbiome2022;10:24 PMCID:PMC8812257

[13] Fleming E,Scholar Z.Cultivation of common bacterial species and strains from human skin, oral, and gut microbiota.BMC Microbiol2021;21:278 PMCID:PMC8515726

[14] Naud S,Mbogning Fonkou MD,Lagier JC.Proof of concept of culturomics use of time of care.Front Cell Infect Microbiol2020;10:524769 PMCID:PMC7719802

[15] Diakite A,Dione N.Optimization and standardization of the culturomics technique for human microbiome exploration.Sci Rep2020;10:9674 PMCID:PMC7295790

[16] Chang Y,Pan Z.Optimization of culturomics strategy in human fecal samples.Front Microbiol2019;10:2891 PMCID:PMC6927924

[17] Kaeberlein T,Epstein SS.Isolating “uncultivable” microorganisms in pure culture in a simulated natural environment.Science2002;296:1127-9

[18] Lugli GA,Duranti S.Isolation of novel gut bifidobacteria using a combination of metagenomic and cultivation approaches.Genome Biol2019;20:96 PMCID:PMC6524291

[19] Kasendra M,Sontheimer-Phelps A.Development of a primary human small intestine-on-a-chip using biopsy-derived organoids.Sci Rep2018;8:2871 PMCID:PMC5811607

[20] Kim HJ,Hamilton G.Human gut-on-a-chip inhabited by microbial flora that experiences intestinal peristalsis-like motions and flow.Lab Chip2012;12:2165-74

[21] Shah P,Glaab E.A microfluidics-based in vitro model of the gastrointestinal human-microbe interface.Nat Commun2016;7:11535 PMCID:PMC4865890

[22] Huh D,Hamilton GA,Ingber DE.Microengineered physiological biomimicry: organs-on-chips.Lab Chip2012;12:2156-64

[23] Hugenholtz F.Mouse models for human intestinal microbiota research: a critical evaluation.Cell Mol Life Sci2018;75:149-60 PMCID:PMC5752736

[24] Nguyen TL,Liston A.How informative is the mouse for human gut microbiota research?.Dis Model Mech2015;8:1-16 PMCID:PMC4283646

[25] Mudd AT.Early-life nutrition and neurodevelopment: use of the piglet as a translational model.Adv Nutr2017;8:92-104 PMCID:PMC5227977

[26] Rose EC,Ziegler AL.Porcine models of the intestinal microbiota: the translational key to understanding how gut commensals contribute to gastrointestinal disease.Front Vet Sci2022;9:834598 PMCID:PMC8990160

[27] Pabst R.The pig as a model for immunology research.Cell Tissue Res2020;380:287-304 PMCID:PMC7223737

[28] Elzinga J,de Vos WM.The use of defined microbial communities to model host-microbe interactions in the human gut.Microbiol Mol Biol Rev2019;83:e00054-18 PMCID:PMC6684003

[29] Arumugam M,Pelletier E.Enterotypes of the human gut microbiome.Nature2011;473:174-80 PMCID:PMC3728647

[30] Trosvik P.Ecology of bacteria in the human gastrointestinal tract-identification of keystone and foundation taxa.Microbiome2015;3:44 PMCID:PMC4601151

[31] Venema K.Experimental models of the gut microbiome.Best Pract Res Clin Gastroenterol2013;27:115-26

[32] Payne AN,Chassard C.Advances and perspectives in in vitro human gut fermentation modeling.Trends Biotechnol2012;30:17-25

[33] Huang W,Meng D.The impact of indole-3-lactic acid on immature intestinal innate immunity and development: a transcriptomic analysis.Sci Rep2021;11:8088 PMCID:PMC8044159

[34] Zeng S,Almeida A.A compendium of 32,277 metagenome-assembled genomes and over 80 million genes from the early-life human gut microbiome.Nat Commun2022;13:5139 PMCID:PMC9437082

[35] Ventura M,Turroni F.Envisioning emerging frontiers on human gut microbiota and its applications.Microb Biotechnol2021;14:12-7 PMCID:PMC7888449